FDA Inspection 1175419 — AmerisourceBergen Drug Corporation
The FDA completed an inspection of AmerisourceBergen Drug Corporation on July 14, 2022 in Amityville, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 14, 2022
- Fiscal Year
- 2022
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Amityville, NY (United States)